Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression
NCT: NCT06986460 · RECRUITING
Brief Summary
The purpose of this trial is to conduct an adequately powered clinical trial of once daily LFR for individuals diagnosed with treatment-resistant BD-DE who have not responded to iTBS or sham treatment applied to the left DLPFC. This work will develop the evidence supporting the use of LFR rTMS for individuals with treatment-resistant BD-DE who currently have limited treatment options to alleviate their suffering. Participants will come for 30 days of LFR, with a 6-week follow-up period. Symptoms of depression (for determining treatment efficacy) and mania (for determining treatment safety) will be assessed using the 17-item Hamilton Rating Scale for Depression (HRSD-17) and the Young Mania Rating Scale (YMRS) every five treatments during the treatment course, and at 1 week and 6 week after treatment completion.
Frequently Asked Questions
What is Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression?
Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression is a clinical trial registered under NCT06986460. Current status: RECRUITING.
What is the status of NCT06986460?
The current status of NCT06986460 (Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression) is: RECRUITING.
When did Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression start?
Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression started on 2025-05-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.